Cellectis S.A. current report, Q4 FY2022

Cellectis S.A. Form 6-K Summary

Business Context and Reporting Period

This Form 6-K was filed by Cellectis S.A., a foreign private issuer headquartered in Paris, France, on November 10, 2022. The filing serves to distribute a press release dated November 10, 2022, as Exhibit 99.1. The registrant files annual reports under Form 20-F.

Financial Metrics

The provided filing text contains only the cover page and exhibit index. It does not include the content of the press release or any financial statements. Consequently, the filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, liquidity, or other key financial metrics.

Material Changes

No material changes versus the prior comparable period can be identified from the provided text, as no financial data or operational updates are included in the cover document.

Guidance, Outlook, and Risks

The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These details are presumably contained within the attached press release (Exhibit 99.1), which is not included in the input content.

Key Facts for Investor Verification

  • Verify the specific content of the press release dated November 10, 2022, referenced as Exhibit 99.1, as the cover page contains no operational details.
  • Confirm the company's current cash position and runway, as no liquidity data is present in this summary text.
  • Review the full Form 20-F for the most recent audited financial statements, as this 6-K does not provide updated figures.